Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
VRME - VerifyMe Inc - Stock Price Chart
TickerVRME [NASD]
CompanyVerifyMe Inc
CountryUSA
IndustrySecurity & Protection Services
Market Cap15.17MEPS (ttm)-0.24
P/E-EPS this Y10.00%
Forward P/E-EPS next Y40.00%
PEG-EPS past 5Y25.98%
P/S0.60EPS next 5Y-
P/B1.22EPS Q/Q67.57%
Dividend-Sales Q/Q1.73%
Insider Own22.43%Inst Own9.52%
Insider Trans2.00%Inst Trans-53.46%
Short Float0.66%EarningsMay 14/b
Analyst Recom1.00Target Price3.00
Avg Volume41.78K52W Range0.85 - 2.45
May-23-24 08:00AM VerifyMe Provides 2024 Outlook Update (PR Newswire) -26.96%
May-20-24 01:51PM 3 Penny Stocks That Could Mint New Millionaires (InvestorPlace)
May-14-24 12:53PM VRME Stock Earnings: VerifyMe Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:00AM VerifyMe Reports Improved First Quarter 2024 Financial Results including a Gross Profit increase of 49% (PR Newswire)
May-07-24 08:00AM VerifyMe to Report First Quarter 2024 Financial Results on May 14, 2024 (PR Newswire) -7.39%
Mar-22-24 10:54AM VerifyMe, Inc. (NASDAQ:VRME) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-21-24 12:52PM VRME Stock Earnings: VerifyMe Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
09:15AM VerifyMe, Inc. (VRME) Q4 Earnings and Revenues Miss Estimates (Zacks)
08:00AM VerifyMe Reports Full Year and Fourth Quarter 2023 Financial Results (PR Newswire)
Mar-20-24 08:00AM Manuka Health Limited leverages VerifyMe QR codes to participate in Amazon Transparency (PR Newswire)
ATFV - Alger 35 ETF - Stock Price Chart
TickerATFV [NYSE]
CompanyAlger 35 ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Factor & Thematic
Index-
TagsGlobal, equity, growth, technology
Sector/Theme Region
Dividend0.01%Active/Passive
Total Holdings-AUM17.22M
Flows% 1M0.00%Flows% 3M2.99%
Flows% YTD9.78%Flows% 1Y
Return% 1Y40.33%Return% 3Y0.03%
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume2.75K52W Range13.67 - 21.17
LINK - Interlink Electronics - Stock Price Chart
TickerLINK [NASD]
CompanyInterlink Electronics
CountryUSA
IndustryElectronic Components
Market Cap48.13MEPS (ttm)-0.12
P/E-EPS this Y-556.25%
Forward P/E-EPS next Y17.14%
PEG-EPS past 5Y-
P/S3.49EPS next 5Y-
P/B3.99EPS Q/Q-190.14%
Dividend-Sales Q/Q-4.70%
Insider Own83.37%Inst Own0.68%
Insider Trans0.00%Inst Trans10.76%
Short Float0.67%EarningsMay 09/b
Analyst Recom1.00Target Price7.00
Avg Volume9.39K52W Range4.25 - 11.49
May-09-24 09:00AM Interlink Electronics Reports First Quarter 2024 Results (PR Newswire)
Mar-27-24 09:02AM LINK Stock Earnings: Interlink Electronics Reported Results for Q4 2023 (InvestorPlace)
Mar-21-24 09:43AM Interlink Electronics Posts Loss In Q4 - Quick Facts (RTT News)
09:00AM Interlink Electronics Reports Fourth Quarter and Fiscal Year 2023 Results (PR Newswire)
Mar-03-24 02:00PM Take Your Profits! 3 High-Flying Tech Stocks to Sell While You Can (InvestorPlace)
Mar-01-24 09:00AM Interlink Electronics Announces 50% Common Stock Dividend (PR Newswire) +11.82%
Feb-29-24 09:00AM Interlink Electronics, Inc. Presenting and Exhibiting at LOPEC 2024 - the world's leading exhibition and conference for flexible, organic, and printed electronics (PR Newswire) -6.48%
Nov-09-23 09:00AM Interlink Electronics Reports Third Quarter 2023 Results (PR Newswire) +5.28%
Oct-09-23 02:29PM Interlink Electronics, Inc. to Present at Maxim Group LLC Virtual Tech Conference Series: Exploring All Corners of the Tech Sector (PR Newswire)
09:55AM Maxim Group LLC to Host the Virtual Tech Conference Series: Exploring All Corners of the Tech Sector, on Tuesday, October 10th & Wednesday, October 11th at 8:30 A.M. E.T. (GlobeNewswire)
CLOZ - Panagram BBB-B CLO ETF - Stock Price Chart
TickerCLOZ [NYSE]
CompanyPanagram BBB-B CLO ETF
CountryUSA
IndustryExchange Traded Fund
CategoryBonds - Non Government Asset Backed Securities
Index-
TagsU.S., debt-securities, high-yield
Sector/Theme Region
Dividend9.25%Active/Passive
Total Holdings132AUM310.26M
Flows% 1M10.44%Flows% 3M46.43%
Flows% YTD69.74%Flows% 1Y
Return% 1Y17.56%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume127.77K52W Range25.12 - 27.01
GLBZ - Glen Burnie Bancorp - Stock Price Chart
TickerGLBZ [NASD]
CompanyGlen Burnie Bancorp
CountryUSA
IndustryBanks - Regional
Market Cap11.86MEPS (ttm)0.35
P/E11.84EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-2.48%
P/S0.82EPS next 5Y-
P/B0.65EPS Q/Q-99.34%
Dividend9.74%Sales Q/Q2.95%
Insider Own18.37%Inst Own4.97%
Insider Trans0.30%Inst Trans11.28%
Short Float0.21%Earnings-
Analyst Recom-Target Price-
Avg Volume4.45K52W Range4.00 - 8.60
Apr-26-24 01:53PM GLBZ Stock Earnings: Glen Burnie Bancorp Reported Results for Q1 2024 (InvestorPlace)
10:28AM Glen Burnie Bancorp Announces First Quarter 2024 Results (GlobeNewswire)
Apr-12-24 09:23AM Glen Burnie Bancorp Declares 1Q 2024 Dividend (GlobeNewswire)
Apr-05-24 09:53AM GLBZ Stock Earnings: Glen Burnie Bancorp Reported Results for Q4 2023 (InvestorPlace)
Feb-16-24 10:08AM Glen Burnie Bancorp Announces Fourth Quarter And Full Year 2023 Results (GlobeNewswire)
Jan-12-24 09:22AM Glen Burnie Bancorp Declares 4Q 2023 Dividend (GlobeNewswire) +5.07%
Oct-31-23 09:46AM Glen Burnie Bancorp Announces Third Quarter 2023 Results (GlobeNewswire)
Oct-13-23 09:13AM Glen Burnie Bancorp Declares 3Q 2023 Dividend (GlobeNewswire)
Sep-20-23 02:00PM Bank of Glen Burnie taps Virginia banker as next CEO (American City Business Journals)
10:47AM Glen Burnie Bancorp Names Mark Hanna as New President and CEO (GlobeNewswire)
FIHL - Fidelis Insurance Holdings Ltd. - Stock Price Chart
TickerFIHL [NYSE, RUT]
CompanyFidelis Insurance Holdings Ltd.
CountryBermuda
IndustryInsurance - Diversified
Market Cap1.92BEPS (ttm)4.08
P/E4.00EPS this Y-9.60%
Forward P/E4.60EPS next Y12.29%
PEG-EPS past 5Y-
P/S0.93EPS next 5Y-
P/B0.76EPS Q/Q-95.39%
Dividend1.64%Sales Q/Q-74.65%
Insider Own65.87%Inst Own28.33%
Insider Trans0.00%Inst Trans-
Short Float4.13%EarningsMay 09/a
Analyst Recom1.75Target Price21.21
Avg Volume715.09K52W Range11.55 - 20.53
May-22-24 10:02PM Fidelis Insurance Group Announces Pricing of Secondary Offering of its Common Shares (Business Wire)
May-20-24 05:31PM Fidelis Insurance Shareholders Price Secondary Common Stock Offering; Shares Fall After Hours (MT Newswires)
05:20PM Fidelis Insurance Group Announces Secondary Offering of its Common Shares (Business Wire)
May-14-24 11:55AM UBS Adjusts Fidelis Insurance Price Target to $22 From $22.50, Maintains Buy Rating (MT Newswires)
May-13-24 12:12PM 14 Best New Stocks To Buy According To Analysts (Insider Monkey)
May-09-24 05:55PM Fidelis Insurance Holdings (FIHL) Lags Q1 Earnings and Revenue Estimates (Zacks)
05:46PM Fidelis Insurance Q1 Operating Earnings, Revenue Decline (MT Newswires)
04:56PM Fidelis Insurance: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM Fidelis Insurance Group Reports 2024 First Quarter Results (Business Wire)
May-08-24 04:15PM Fidelis Insurance Group Declares Quarterly Dividend (Business Wire)
EAGL - Eagle Capital Select Equity ETF - Stock Price Chart
TickerEAGL [NYSE]
CompanyEagle Capital Select Equity ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - US Style
Index-
TagsGlobal, equity, large-cap, quality
Sector/Theme Region
Dividend-Active/Passive
Total Holdings28AUM1.89B
Flows% 1M0.98%Flows% 3M2.42%
Flows% YTD2.42%Flows% 1Y
Return% 1Y-Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume64.87K52W Range24.65 - 26.21
EVOK - Evoke Pharma Inc - Stock Price Chart
TickerEVOK [NASD]
CompanyEvoke Pharma Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap4.00MEPS (ttm)-1.83
P/E-EPS this Y96.57%
Forward P/E4.65EPS next Y225.00%
PEG-EPS past 5Y15.68%
P/S0.65EPS next 5Y40.00%
P/B1.14EPS Q/Q74.07%
Dividend-Sales Q/Q114.15%
Insider Own19.32%Inst Own36.79%
Insider Trans0.00%Inst Trans-4.54%
Short Float0.55%EarningsMay 14/a
Analyst Recom1.00Target Price7.00
Avg Volume32.06K52W Range0.41 - 2.16
May-16-24 04:02PM Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference (GlobeNewswire)
May-14-24 10:53PM EVOK Stock Earnings: Evoke Pharma Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:15PM Evoke Pharma Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-17-24 08:30AM Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications (GlobeNewswire) +16.81%
Mar-21-24 04:15PM Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer (GlobeNewswire)
Mar-15-24 01:58PM Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript (Insider Monkey) -8.09%
06:56AM Q4 2023 Evoke Pharma Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 04:05PM Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire) +5.24%
Mar-07-24 04:10PM Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024 (GlobeNewswire)
Feb-14-24 07:30AM Evoke Pharma Announces Closing of $7.5 Million Public Offering (GlobeNewswire)
ITIC - Investors Title Co. - Stock Price Chart
TickerITIC [NASD, RUT]
CompanyInvestors Title Co.
CountryUSA
IndustryInsurance - Specialty
Market Cap283.65MEPS (ttm)13.23
P/E11.41EPS this Y-
Forward P/E-EPS next Y-
PEG2.85EPS past 5Y-0.15%
P/S1.25EPS next 5Y4.00%
P/B1.12EPS Q/Q284.74%
Dividend1.20%Sales Q/Q4.12%
Insider Own25.23%Inst Own47.63%
Insider Trans0.00%Inst Trans-1.69%
Short Float0.39%EarningsFeb 13/b
Analyst Recom-Target Price-
Avg Volume2.20K52W Range124.39 - 171.60
May-15-24 04:30PM Investors Title Company Declares Quarterly Dividend (Business Wire)
May-03-24 12:52PM ITIC Stock Earnings: Investors Title Reported Results for Q1 2024 (InvestorPlace)
09:53AM Investors Title Co Reports Substantial Earnings Growth in Q1 2024 (GuruFocus.com)
08:33AM Investors Title: Q1 Earnings Snapshot (Associated Press Finance)
08:29AM Investors Title Company Announces First Quarter 2024 Results (Business Wire)
Mar-04-24 04:31PM Investors Title Company Declares Quarterly Dividend (Business Wire)
Feb-13-24 08:52AM Investors Title Co Reports Decline in Q4 and Full-Year 2023 Earnings Amid Real Estate Slowdown (GuruFocus.com) -8.55%
08:45AM Investors Title: Q4 Earnings Snapshot (Associated Press Finance)
08:29AM Investors Title Company Announces Fourth Quarter and Fiscal Year 2023 Financial Results (Business Wire)
Feb-08-24 06:02AM Don't Miss These 2 Brilliant Dividend Stocks to Buy Now (Motley Fool)
BCYC - Bicycle Therapeutics Plc ADR - Stock Price Chart
TickerBCYC [NASD]
CompanyBicycle Therapeutics Plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap1.00BEPS (ttm)-4.46
P/E-EPS this Y12.57%
Forward P/E-EPS next Y-14.44%
PEG-EPS past 5Y-12.36%
P/S24.03EPS next 5Y-
P/B2.81EPS Q/Q52.52%
Dividend-Sales Q/Q295.08%
Insider Own1.19%Inst Own79.14%
Insider Trans-5.07%Inst Trans2.12%
Short Float6.62%EarningsMay 02/b
Analyst Recom1.25Target Price43.20
Avg Volume356.84K52W Range12.54 - 28.91
May-23-24 05:05PM Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting (Business Wire) +9.62%
07:00AM Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing (Business Wire)
May-21-24 09:40AM Is Bicycle Therapeutics (BCYC) Outperforming Other Medical Stocks This Year? (Zacks)
May-16-24 05:23PM Stanley Druckenmiller Bet On Biotech, Financial Services in Q1, Trimmed Nvidia Stake (Investopedia)
May-06-24 12:00PM Bicycle Therapeutics (BCYC) Moves to Buy: Rationale Behind the Upgrade (Zacks) -5.21%
09:55AM Wall Street Analysts See a 77.22% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High? (Zacks)
May-02-24 01:54PM BCYC Stock Earnings: Bicycle Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:44AM Bicycle Therapeutics PLC (BCYC) Q1 2024 Earnings: Narrowing Losses Amidst Robust R&D Progress (GuruFocus.com)
07:00AM Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results (Business Wire)
Apr-24-24 10:05AM Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting (Business Wire)
1⋯56789101112131415⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.